EHR

Brainomix and Endeavor BioMedicines Present Positive Results from Quantitative Image Analysis of Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Trial at ERS Congress

AI-powered quantitative CT analysis with Brainomix 360 e-Lung was used in Endeavor BioMedicines ENV-IPF-101 Phase 2a trial of taladegib. Results...

1upHealth Launches 1up Clinical Connect to Help Payers Strengthen HEDIS Scores, Star Ratings, and Financial Performance with Continuous Clinical Data

Interoperability Leader Announces Capital Health Plan as Inaugural User of New Solution BOSTON, MA / ACCESS Newswire / September 1,...

Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis

Boehringer headquarters Ingelheim, Germany Ingelheim, Germany, and Bracknell, United Kingdom SCOVELLA® is the first therapy specifically developed and approved for...

error: Content is protected !!